These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 33034214)
1. What is the future of patient-reported outcomes in sickle-cell disease? Singh SA; Bakshi N; Mahajan P; Morris CR Expert Rev Hematol; 2020 Nov; 13(11):1165-1173. PubMed ID: 33034214 [TBL] [Abstract][Full Text] [Related]
2. Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠. Keller S; Yang M; Treadwell MJ; Hassell KL Health Qual Life Outcomes; 2017 Jun; 15(1):117. PubMed ID: 28577358 [TBL] [Abstract][Full Text] [Related]
3. Psychometric analysis of the adult sickle cell quality of life measurement information system (ACSQ-Me) in a UK population. Cooper O; McBain H; Tangayi S; Telfer P; Tsitsikas D; Yardumian A; Mulligan K Health Qual Life Outcomes; 2019 Apr; 17(1):74. PubMed ID: 31036017 [TBL] [Abstract][Full Text] [Related]
4. Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks. Keller SD; Yang M; Treadwell MJ; Werner EM; Hassell KL Health Qual Life Outcomes; 2014 Aug; 12():125. PubMed ID: 25146160 [TBL] [Abstract][Full Text] [Related]
5. Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease. Mucalo L; Field JJ; Highland J; Khan H; Hankins JS; Singh A; Brandow AM Blood Adv; 2023 Jul; 7(14):3658-3665. PubMed ID: 37058480 [TBL] [Abstract][Full Text] [Related]
6. Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium. Knisely MR; Pugh N; Kroner B; Masese R; Gordeuk V; King AA; Smith SM; Gurney JG; Adams R; Wun T; Snyder A; Glassberg J; Shah N; Treadwell M; Am J Hematol; 2020 Sep; 95(9):1066-1074. PubMed ID: 32449965 [TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in hemoglobinopathies: A systematic review from a global perspective. Rodigari F; Brugnera G; Colombatti R Front Pediatr; 2022; 10():886674. PubMed ID: 36090573 [TBL] [Abstract][Full Text] [Related]
8. Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease. Sarri G; Bhor M; Abogunrin S; Farmer C; Nandal S; Halloway R; Revicki DA Health Qual Life Outcomes; 2018 May; 16(1):99. PubMed ID: 29784054 [TBL] [Abstract][Full Text] [Related]
9. Clinical trial considerations in sickle cell disease: patient-reported outcomes, data elements, and the stakeholder engagement framework. Badawy SM Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):196-205. PubMed ID: 34889394 [TBL] [Abstract][Full Text] [Related]
10. The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease. Rizio AA; Bhor M; Lin X; McCausland KL; White MK; Paulose J; Nandal S; Halloway RI; Bronté-Hall L Qual Life Res; 2020 Jun; 29(6):1533-1547. PubMed ID: 31933113 [TBL] [Abstract][Full Text] [Related]
11. Adult sickle cell quality-of-life measurement information system (ASCQ-Me): conceptual model based on review of the literature and formative research. Treadwell MJ; Hassell K; Levine R; Keller S Clin J Pain; 2014 Oct; 30(10):902-14. PubMed ID: 24300219 [TBL] [Abstract][Full Text] [Related]
12. Sickle cell disease: A primary care update. Onimoe G; Rotz S Cleve Clin J Med; 2020 Jan; 87(1):19-27. PubMed ID: 31990651 [TBL] [Abstract][Full Text] [Related]
13. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults. Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417 [TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease. Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27896936 [TBL] [Abstract][Full Text] [Related]
15. CDC Grand Rounds: Improving the Lives of Persons with Sickle Cell Disease. Hulihan M; Hassell KL; Raphael JL; Smith-Whitley K; Thorpe P MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(46):1269-1271. PubMed ID: 29166365 [TBL] [Abstract][Full Text] [Related]
16. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083 [TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease. Bhatia M; Kolva E; Cimini L; Jin Z; Satwani P; Savone M; George D; Garvin J; Paz ML; Briamonte C; Cruz-Arrieta E; Sands S Biol Blood Marrow Transplant; 2015 Apr; 21(4):666-72. PubMed ID: 25559691 [TBL] [Abstract][Full Text] [Related]
18. Cognitive functioning, patient health communication, and worry mediate pain predictive effects on health-related quality of life in youth with sickle cell disease. Varni JW; Panepinto JA Pediatr Blood Cancer; 2020 Nov; 67(11):e28680. PubMed ID: 32860648 [TBL] [Abstract][Full Text] [Related]
20. Stigma and quality of life in adults with sickle cell disease in Jamaica and the United States. Bulgin D; Asnani M; Vorderstrasse A; Royal C; Pan W; Tanabe P Psychol Health Med; 2023 Jun; 28(5):1133-1147. PubMed ID: 34957879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]